Generate Biomedicines partners with Zealand Pharma to develop AI — designed protein therapeutics for metabolic diseases
Generate Biomedicines entered a multi-target collaboration with Zealand Pharma to develop AI-engineered multispecific protein therapeutics for obesity. Agreement targets obesity and other metabolic diseases, combining Zealand’s metabolic expertise with Generate’s generative AI and experimental validation platform. Deal